STAAR Surgical Company is the subject of a proposed acquisition by Alcon Inc. The shareholder vote on this transaction, initially scheduled for October 23, 2025, has been postponed multiple times due to ongoing concerns and apparent resistance from shareholders and proxy advisory firms. The vote was most recently rescheduled to January 6, 2026, marking the fourth delay in the process. Broadwood Partners, a major STAAR shareholder, has expressed continued skepticism about the deal’s process, timing, and valuation, noting that opposition persists despite extensive efforts by STAAR and Alcon to promote the transaction.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. STAAR Surgical Company published the original content used to generate this news brief via Business Wire (Ref. ID: 20251219413594) on December 19, 2025, and is solely responsible for the information contained therein.